Philippe STEG, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Servier
    Topic: 
    CLARIFY registry
    Date added: 
    04/13/2022
    Relationship end date: 
    01/01/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Amarin
    Topic: 
    REDUCE IT trial
    Date added: 
    04/13/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    AstraZeneca
    Topic: 
    Atherosclerosis research
    Date added: 
    04/13/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Amgen
    Topic: 
    Consulting
    Date added: 
    04/13/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Novartis
    Topic: 
    Chair Victorion 2P trial
    Date added: 
    04/13/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Janssen
    Topic: 
    Chair Milvexian ACS trial
    Date added: 
    04/13/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Novo Nordisk
    Topic: 
    Consulting and speaking
    Date added: 
    04/13/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sanofi
    Topic: 
    Consulting and speaking
    Date added: 
    04/13/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    KOWA
    Topic: 
    Steering Committee PROMINENT trial
    Date added: 
    04/13/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    LEXICON
    Topic: 
    Chair SCORED trial
    Date added: 
    04/13/2022

Pages

Return to 103 Cardiology Grand Rounds: “Lessons from the CLARIFY International Registry of Chronic Coronary Artery Disease” (042022)